Details for Patent: 11,331,315
Which drugs does patent 11,331,315 protect, and when does it expire?
Patent 11,331,315 protects OPIPZA and is included in one NDA.
This patent has one patent family member in one country.
Summary for Patent: 11,331,315
| Title: | Aripiprazole oral soluble film |
| Abstract: | The present invention is directed to an aripiprazole oral soluble film and a preparation method thereof. The aripiprazole oral soluble film comprises 10-60% w/w of aripiprazole in a crystalline state and 30-95% w/w of one or more film-forming materials, wherein 90% of the aripiprazole particles have a size of ≤14.3 μm and are uniformly blended in the film without visible undispersed particles. The aripiprazole oral soluble film has excellent bioavailability, uniformity, stability, and palatability. The oral soluble film preparation is prepared by first grinding aripiprazole particles to have desired small particle sizes, then blending the aripiprazole particles with film forming materials in an aqueous solution to a uniform suspension, defoaming the suspension, and coating the suspension on a substrate and drying it to form a film. |
| Inventor(s): | Rongbin Ling, Lingyu Cai, Fuxiang LIN, Yong Yu, Xiaojin Xiao |
| Assignee: | Xiamen LP Pharmaceutical Co Ltd |
| Application Number: | US17/087,949 |
|
Patent Claim Types: see list of patent claims | Compound; |
Drugs Protected by US Patent 11,331,315
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Xiamen Lp Pharm Co | OPIPZA | aripiprazole | FILM;ORAL | 216655-001 | Jul 22, 2024 | RX | Yes | No | 11,331,315 | ⤷ Start Trial | Y | ⤷ Start Trial | ||||
| Xiamen Lp Pharm Co | OPIPZA | aripiprazole | FILM;ORAL | 216655-002 | Jul 22, 2024 | RX | Yes | No | 11,331,315 | ⤷ Start Trial | Y | ⤷ Start Trial | ||||
| Xiamen Lp Pharm Co | OPIPZA | aripiprazole | FILM;ORAL | 216655-003 | Jul 22, 2024 | RX | Yes | Yes | 11,331,315 | ⤷ Start Trial | Y | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,331,315
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| China | 111991373 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
